US 7,585,843 B2
	Treatment of demyelinating autoimmune disease with modified ordered peptides
Hideki Garren, Palo Alto, Calif. (US); and Stephanie Broome, Palo Alto, Calif. (US)
Assigned to Bayhill Therapeutics, Inc., San Mateo, Calif. (US)
Appl. No. 10/589,067 PCT Filed Oct. 01, 2004, PCT No. PCT/US2004/032598 § 371(c)(1), (2), (4) Date Mar. 30, 2007, PCT Pub. No. WO2005/032482, PCT Pub. Date Apr. 14, 2005.
Claims priority of provisional application 60/508350, filed on Oct. 03, 2003.
Prior Publication US 2007/0275899 A1, Nov. 29, 2007
Int. Cl. A61K 38/10 (2006.01)

U.S. Cl. 514—14

6 Claims

1. A modified therapeutic ordered peptide consisting of D-Ala-EYYKEYYKEYYK-NH2.